Leo Cancer Care

Leo Cancer Care is a health care startup founded in 2014 in the United Kingdom with a slogan of “THE MORE HUMAN WAY TO TREAT CANCER.” The company aims to improve the quality and accessibility of Radiation Therapy by introducing innovative technology and approaches.

Leo Cancer Care was founded with over 100 years of Radiation Therapy experience and is led by a dedicated team committed to challenging industry norms. The company's primary goals are to enhance patient care and experience, as well as to increase the accessibility of cancer treatments for more patients in more places.

The startup’s unique approach involves upright patient positioning and a shift from machine rotation to patient rotation, which has been built on research from across the globe, demonstrating the clinical benefits of upright patient positioning in cancer treatment.

Despite the products not being commercially available at this stage and undergoing the process of FDA approval and CE mark, Leo Cancer Care has attracted significant funding, with its Series C investment on 11th June 2024 being backed by a consortium of notable investors including EDBI, WARF, Cicada Innovations, Aviko Radiopharmaceuticals, Macmillan Cancer Support, McLaren Health Care, and Cone Health.

Overall, Leo Cancer Care's innovative approach, strong leadership, and the support of reputable investors position it as a promising player in revolutionizing the field of Radiation Therapy, with the potential to make a significant impact on cancer treatment globally.